InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
7
T+90 hit rate
50%
T+90 mean return
-17.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by SMITH PATRICK F, Président, Développement Intégré des Médicaments. Director active across 2 companies, notably Certara, Inc.. Aggregated, 13 disclosures have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €989k. Activity tracked since 1 November 2021. The latest transaction was filed on 7 October 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
5,409 shares@ US$11.035.0% of flowCommon StockSEC:0001415889-24-024874:0
7,151 shares0Common StockSEC:0001415889-24-024816:0
5,264 shares@ US$16.767.5% of flowCommon StockSEC:0001415889-24-010291:0
1,532 shares@ US$17.882.3% of flowCommon StockSEC:0001415889-24-010073:0
5,000 shares@ US$18.007.6% of flowCommon StockSEC:0001415889-24-004633:0
19,104 shares@ US$21.5535.2% of flowCommon StockSEC:0001415889-23-009326:0
1,532 shares@ US$23.803.1% of flowCommon StockSEC:0001415889-23-005808:0
2,387 shares@ US$13.482.9% of flowCommon StockSEC:0001415889-22-011348:0
1,244 shares@ US$12.231.4% of flowCommon StockSEC:0001415889-22-011013:0
10,000 shares@ US$17.7115.9% of flowCommon StockSEC:0001415889-22-008824:0
10,000 shares@ US$19.160.013% mcap85.7% of flowCommon StockSEC:0001415889-22-006381:0
1,532 shares@ US$21.480.0021% mcap14.3% of flowCommon StockSEC:0001415889-22-003827:0
3,631 shares0Common StockSEC:0001415889-21-005033:0
13 of 13 declarations
About SMITH PATRICK F
Patrick F. Smith is the President of Integrated Drug Development at Certara, Inc. He leads integrated drug development initiatives, focusing on innovation and process efficiency.
